NOS2 and neoplasm: As pointed out in preceding sections, the ability of iNOS/NO to provide tumor cells with a survival, growth, and migratory advantage is often based on suppression by iNOS-specific activity inhibitors (e.g., 1400 W, GW274150) or by a NO scavenger (e.g., cPTIO).